Study to Evaluate OrienX010 in Combination With JS001 in the Treatment of Stage IV (M1c) Liver Metastasis From Melanoma
Clinical trial NCT04206358 · UNKNOWN
Trial details
- NCT number
- NCT04206358
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-13
- Primary completion
- 2021-02-27
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.